Skip to main content

HighTower Advisors, LLC

Position in HRTX — Heron Therapeutics, Inc. /De/

CIK 1462245 CHICAGO, IL

Position in HRTX

as of Jun 30, 2026 · filed Aug 5, 2026
Position Value
$10,585
-$3,504 QoQ
Shares Held
24,617
+39.8% QoQ
Ownership
0.013%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#100
of 161 holders
Holding Since
Jun 2020
13 quarters on record
Voting authority Sole 100% Shared 0% None 0%

Common Shares in HRTX Over Time

Shares Held

Position Value (USD)

Derivatives in HRTX

reported options exposure · as of Jun 30, 2020
CallValue
$4,413
CallShares
300
PutValue
$0
PutShares
0

Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.

Position in Biotechnology

Healthcare · as of Jun 30, 2026

HighTower Advisors, LLC holds $312,855,129 across 115 Biotechnology names. HRTX ranks #112 (0.0% of the industry book) .

# Ticker Company Shares Value (USD) Open

All Filings in HRTX

Export CSV
14 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $10,585 24,617
2026-03-31 $14,089 17,612
2025-12-31 $21,834 16,796
2025-09-30 $26,202 20,796
2025-06-30 $43,047 20,796
2025-03-31 $45,751 20,796
2024-12-31 $24,828 16,228
2024-09-30 $33,288 16,728
2024-06-30 $43,851 12,529
2024-03-31 $117,805 42,529
2023-12-31 $123,353 72,561
2023-09-30 $11,082 10,760
2020-06-30 $4,413 300
2020-06-30 $144,481 9,822